PACIRA BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $7.0M | $-99.6M | $42.0M | $15.9M | $42.0M | $145.5M | $-11.0M | $-471.0K |
| Depreciation & Amortization | $91.0M | $78.8M | $75.6M | $91.5M | $28.5M | $19.9M | $19.6M | $13.2M |
| Depreciation | $33.7M | $21.5M | $18.3M | $34.2M | $15.0M | $12.0M | $14.0M | $13.2M |
| Amortization | $57.3M | $57.3M | $57.3M | $57.3M | $13.6M | $7.9M | $5.7M | $0 |
| Stock-Based Compensation | $57.5M | $51.2M | $47.9M | $48.1M | $42.2M | $39.9M | $33.7M | $31.7M |
| Net Cash from Operating Activities | $152.0M | $189.4M | $154.6M | $145.3M | $125.7M | $77.0M | $70.5M | $48.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $15.3M | $10.6M | $15.2M | $30.1M | $45.9M | $37.8M | $10.2M | $14.5M |
| Business Acquisitions | $16.7M | $0 | $0 | $0 | $420.0M | $0 | $117.7M | $0 |
| Net Cash from Investing Activities | $99.5M | $-83.3M | $77.5M | $-225.2M | $-20.8M | $-277.6M | $-128.5M | $20.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $148.3M | $25.0M | $0 | $0 | — | — | — | — |
| Net Cash from Financing Activities | $-369.6M | $17.4M | $-183.0M | $-401.5M | $380.7M | $222.3M | $3.7M | $9.0M |
| Net Change in Cash | $-118.2M | $123.5M | $49.2M | $-481.4M | $485.6M | $21.7M | $-54.3M | $78.4M |
| Free Cash Flow | $136.7M | $178.8M | $139.5M | $115.2M | $79.9M | $39.2M | $60.4M | $34.4M |